183 related articles for article (PubMed ID: 21850230)
21. [Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y].
Pilunov AM; Kuchmiy AA; Sheetikov SA; Filkin SY; Romaniuk DS; Rosov FN; Efimov GA
Mol Biol (Mosk); 2019; 53(3):456-466. PubMed ID: 31184611
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis.
Overes IM; Levenga TH; Vos JC; van Horssen-Zoetbrood A; van der Voort R; De Mulder PH; de Witte TM; Dolstra H
Cancer Immunol Immunother; 2009 Mar; 58(3):429-39. PubMed ID: 18719914
[TBL] [Abstract][Full Text] [Related]
23. Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2.
Pont MJ; van der Lee DI; van der Meijden ED; van Bergen CA; Kester MG; Honders MW; Vermaat M; Eefting M; Marijt EW; Kielbasa SM; Hoen PA; Falkenburg JH; Griffioen M
Clin Cancer Res; 2016 Aug; 22(16):4185-96. PubMed ID: 26964570
[TBL] [Abstract][Full Text] [Related]
24. Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2.
Weng X; Liang Z; Lu X; Zhong M; Lu S; Zhang C; Deng J; Wu X; Gong F
Sci China C Life Sci; 2007 Apr; 50(2):203-11. PubMed ID: 17447027
[TBL] [Abstract][Full Text] [Related]
25. Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
Nicholls S; Piper KP; Mohammed F; Dafforn TR; Tenzer S; Salim M; Mahendra P; Craddock C; van Endert P; Schild H; Cobbold M; Engelhard VH; Moss PA; Willcox BE
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3889-94. PubMed ID: 19234124
[TBL] [Abstract][Full Text] [Related]
26. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
Chao NJ
Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
[TBL] [Abstract][Full Text] [Related]
27. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
[TBL] [Abstract][Full Text] [Related]
28. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
van der Waart AB; Fredrix H; van der Voort R; Schaap N; Hobo W; Dolstra H
Cancer Immunol Immunother; 2015 May; 64(5):645-54. PubMed ID: 25724840
[TBL] [Abstract][Full Text] [Related]
29. A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity.
Roex MCJ; Hageman L; Veld SAJ; van Egmond E; Hoogstraten C; Stemberger C; Germeroth L; Einsele H; Falkenburg JHF; Jedema I
Blood; 2020 Jul; 136(4):455-467. PubMed ID: 32483595
[TBL] [Abstract][Full Text] [Related]
30. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
31. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
[TBL] [Abstract][Full Text] [Related]
32. miHA-Match: computational detection of tissue-specific minor histocompatibility antigens.
Feldhahn M; Dönnes P; Schubert B; Schilbach K; Rammensee HG; Kohlbacher O
J Immunol Methods; 2012 Dec; 386(1-2):94-100. PubMed ID: 22985828
[TBL] [Abstract][Full Text] [Related]
33. Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface.
Bijen HM; Hassan C; Kester MGD; Janssen GMC; Hombrink P; de Ru AH; Drijfhout JW; Meiring HD; de Jong AP; Falkenburg JHF; Jimenez CR; Heemskerk MHM; van Veelen PA
Proteomics; 2018 Jun; 18(12):e1700250. PubMed ID: 29251415
[TBL] [Abstract][Full Text] [Related]
34. Rapid Multiplex Genotyping of 20 HLA-A
Romaniuk DS; Postovskaya AM; Khmelevskaya AA; Malko DB; Efimov GA
Front Immunol; 2019; 10():1226. PubMed ID: 31275297
[TBL] [Abstract][Full Text] [Related]
35. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
Tykodi SS; Fujii N; Vigneron N; Lu SM; Mito JK; Miranda MX; Chou J; Voong LN; Thompson JA; Sandmaier BM; Cresswell P; Van den Eynde B; Riddell SR; Warren EH
Clin Cancer Res; 2008 Aug; 14(16):5260-9. PubMed ID: 18698046
[TBL] [Abstract][Full Text] [Related]
36. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
van Buuren MM; Dijkgraaf FE; Linnemann C; Toebes M; Chang CX; Mok JY; Nguyen M; van Esch WJ; Kvistborg P; Grotenbreg GM; Schumacher TN
J Immunol; 2014 Jan; 192(2):641-8. PubMed ID: 24342804
[TBL] [Abstract][Full Text] [Related]
37. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
38. Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation.
Hobo W; Broen K; van der Velden WJ; Greupink-Draaisma A; Adisty N; Wouters Y; Kester M; Fredrix H; Jansen JH; van der Reijden B; Falkenburg JH; de Witte T; Preijers F; Schattenberg T; Feuth T; Blijlevens NM; Schaap N; Dolstra H
Biol Blood Marrow Transplant; 2013 Feb; 19(2):274-82. PubMed ID: 23022467
[TBL] [Abstract][Full Text] [Related]
39. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
[TBL] [Abstract][Full Text] [Related]
40. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.
Fuchs KJ; van de Meent M; Honders MW; Khatri I; Kester MGD; Koster EAS; Koutsoumpli G; de Ru AH; van Bergen CAM; van Veelen PA; 't Hoen PAC; van Balen P; van den Akker EB; Veelken JH; Halkes CJM; Falkenburg JHF; Griffioen M
Blood; 2024 May; 143(18):1856-1872. PubMed ID: 38427583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
